文献速递临床试验与 GCP真实世界研究与卫生经济

精神卫生专家视频会诊对比常规治疗:抑郁症或焦虑障碍初级保健随机优效性试验方案(PROVIDE-C试验)

Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial).
PubMed 文献 · Trials · 2021-05-05

德国初级保健中,N=320名焦虑和/或抑郁障碍患者将个体随机分为精神卫生专家视频会诊干预组与全科医生常规治疗组,比较6个月时PHQ-ADS症状严重度绝对变化这一主要结局的有效性、成本效果和不良反应,随访至12个月,按意向性治疗分析。

要点

  • 首个在德国全科患者中评估视频整合照护模式治疗焦虑抑郁障碍的确证性研究。
  • 主要结局为基线至6个月PHQ-ADS抑郁和焦虑症状严重度均值的绝对变化。
  • 样本量N=320,个体随机、平行组、优效性设计,盲法评估结局。

核心结论

  • 该试验旨在检验精神卫生专家视频会诊模型对比全科医生常规治疗在初级保健抑郁或焦虑障碍患者中的有效性和成本效果。

研究设计与样本

  • 个体随机、前瞻性、两臂平行组优效性试验,计划在德国全科诊所招募N=320名焦虑和/或抑郁障碍患者。
  • 干预为基于视频会诊的新治疗模型,聚焦诊断、治疗计划和精神卫生专家的短期干预,对照组为全科医生常规治疗。
  • 随访由盲法结局评估者在基线后6个月和12个月进行,主要分析基于意向性治疗原则。

关键数值与推荐

  • 主要结局为基线至6个月时患者健康问卷焦虑抑郁量表(PHQ-ADS)测量的抑郁和焦虑症状严重度均值的绝对变化。
  • 通过严格的患者纳入标准、增强干预完整性和实施过程评估来优化治疗有效性的可能性。

临床怎么用

  • 若证实有效,视频会诊模型可为初级保健中需要专科精神卫生服务的抑郁或焦虑障碍患者提供可及性更高的整合照护选项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most people with mental disorders, including those with severe and chronic disorders, are treated solely by their general practitioner (GP). Nevertheless, specialised mental health care may be required for specific patients. Notably, the accessibility of mental health specialist care is mainly complicated by (a) long waiting times for an appointment with specialists, (b) long travel distances to specialists, particularly in rural and remote areas, and (c) patients' reservations about mental health specialist care (including fear of being stigmatised by seeking such care). To mitigate those barriers, technology-based integrated care models have been proposed. The purpose of this study is to examine the effectiveness and cost-effectiveness of a mental health specialist video consultations model versus treatment as usual in patients with depression or anxiety disorders in primary care. METHODS: In an individually randomised, prospective, two-arm superiority trial with parallel group design, N = 320 patients with anxiety and/or depressive disorder will be recruited in general practices in Germany. The intervention includes a newly developed treatment model based on video consultations with focus on diagnostics, treatment planning, and short-term intervention by mental health specialists. We will systematically compare the effectiveness, cost-effectiveness, and adverse effects of this new model with usual care by the GP: the primary outcome is the absolute change in the mean depressive and anxiety symptom severity measured on the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS) from baseline to 6 months after baseline assessment. Follow-up in both groups will be conducted by blinded outcome assessors at 6 months and 12 months after baseline. The main analysis will be based on the intention-to-treat principle. We will optimise the likelihood of treatment effectiveness by strict inclusion criteria for patients, enhanced intervention integrity, and conducting a process evaluation. DISCUSSION: To the best of our knowledge, this is the first confirmatory study on a video-based, integrated care model for the treatment of anxiety and depressive disorders in GP patients in Germany. TRIAL REGISTRATION: ClinicalTrials.gov, United States National Institutes of Health NCT04316572 . Prospectively registered on 20 March 2020.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Haun MW, Tönnies J, Krisam R, et al. Mental health specialist video consultations versus treatment as usual in patients with depression or anxiety disorders in primary care: study protocol for an individually randomised superiority trial (the PROVIDE-C trial). Trials. 2021. PMID: 33952313. doi:10.1186/s13063-021-05289-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。